MSD PHARMACEUTICALS LLC (Development Specialist)
The article deals with the problem of comorbidity of chronic obstructive pulmonary disease and cardiovascular diseases, which has acquired the character of syndemia to date. The prevalence of these pathologies and their joint course is analyzed. The general pathophysiological mechanisms and biomarkers underlying the mutually aggravating course of these pathologies are described. Attention is paid to the peculiarities of the use of cardiovascular drugs in patients with chronic obstructive pulmonary disease and their effect on the course of respiratory pathology. The prognostic value of comorbidity of the described continuum and the associated increased risk of adverse outcomes are considered.
chronic obstructive pulmonary disease, comorbidity, cardiovascular diseases, syndemia, predictive diagnosis
1. Dolgopolova, D. A. Novye podhody k ocenke hronicheskoy obstruktivnoy bolezni legkih na Severe: opredelenie gruppy riska / D. A. Dolgopolova, I. I. Zayceva // Vrach-aspirant. – 2014. – T. 65, № 4. – S. 11-16. – EDN SZEPRZ.
2. Dolgopolova, D. A. Prognozirovanie koronarnyh sobytiy na osnove analiza dinamiki morfofunkcional'nyh parametrov serdechno-sosudistoy sistemy u bol'nyh hronicheskoy obstruktivnoy bolezn'yu legkih na severe / D. A. Dolgopolova, M. A. Popova, N. N. Terent'eva // Arhiv' vnutrenney mediciny. – 2018. – № 1. T.8 S. 36-44. – EDN FZXVUD.
3. Tilik T.V. Molekulyarno-geneticheskie markery metabolizma soedinitel'noy tkani pri hronicheskoy obstruktivnoy bolezni legkih i ee sochetanii s ishemicheskoy bolezn'yu serdca : avtoref. dis. … kand. med. nauk : 14.01.04. Vladivostok. 2012; 21.
4. Risk of Coronary Heart Disease in People with Chronic Obstructive Pulmonary Disease: A Meta-Analysis. https://www.researchgate.net/publication/355671444_Risk_of_Coronary_Heart_Disease_in_ People_with_Chronic_Obstructive_Pulmonary_Disease_A_Meta-Analysis.
5. Almagro P, Boixeda R, Diez-Manglano J, Gómez-Antúnez M, López-García F, Recio J. Insights into chronic obstructive pulmonary disease as critical risk factor for cardiovascular disease. Int J Chron Obstruct Pulmon Dis. 2020;15:755–764. doihttps://doi.org/10.2147/COPD.S238214.
6. Kunisaki KM, Dransfield MT, Anderson JA, et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial. Am J Respir Crit Care Med. 2018;198(1):51–57. doihttps://doi.org/10.1164/rccm.201711-2239OC.
7. Crisan L, Wong N, Sin DD, Lee HM. Karma of cardiovascular disease risk factors for prevention and management of major cardiovascular events in the context of acute exacerbations of chronic obstructive pulmonary disease. Front Cardiovasc Med. 2019;6:79. doihttps://doi.org/10.3389/fcvm.2019.00079.
8. Ingebrigtsen TS, Marott JL, Vestbo J, Nordestgaard BG, Lange P. Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap. BMJ Open Respir Res. 2020;7(1):e000470. doihttps://doi.org/10.1136/bmjresp-2019-000470.
